Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Osteoporosis Screening Prevents Fractures

By HospiMedica staff writers
Posted on 17 Feb 2005
Investigators have determined that osteoporosis screening in individuals aged 65 and over can prevent a large percentage of hip fractures. More...
They found that using bone densitometry screening was associated with a 36% decrease in hip fractures over a six-year-time period compared with the usual medical care.

The study, conducted by researchers at Johns Hopkins University (Baltimore, MD, USA), was published in the February 1, 2005, issue of the journal Annals of Internal Medicine. The study is a novel approach at assessing the effects of osteoporosis screening for both men and women, evaluating 3,107 individuals from the Cardiovascular Health Study (CHS). The CHS was created to establish risk factors for cardiovascular disease in older adults.

"Although some groups recommend screening for osteoporosis, no study had proven that screening prevents fractures. This study provides new evidence for the effectiveness of osteoporosis screening,” stated the lead investigator of the study, Lisa Kern, M.D., M.P.H., from Johns Hopkins University School of Medicine.

To evaluate the advantages of osteoporosis screening, the investigators assessed 3,107 men and women, aged 65 or older, who were part of the CHS from 1994 to 1995. Participants already diagnosed with osteoporosis or who had a previous hip fracture and those taking bisphosphonate drugs were excluded. The scientists discovered that hip fractures occurred in 33 screened individuals (about five fractures/1,000 person-years) and 69 usual-care participants (about eight fractures/1,000 person-years).

"This difference is statistically significant, but there were some other differences between the groups that can partially explain the variance in the incidence of hip fracture. Surprisingly, differences in prescription of vitamin D, calcium, estrogen, and bisphosphonates did not account for the entire difference in hip fractures,” said Dr. Kern.

The study did not gather data on behavioral changes, including the use of fall-preventative strategies or increased physical activity, and even though it was not randomized, the study was the best way currently to assess the effectiveness of screening, according to the researchers.




Related Links:
Johns Hopkins University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.